Safety of revaccination with pneumococcal polysaccharide vaccine.
暂无分享,去创建一个
R. Thompson | G. Carlone | J. Butler | F. Destefano | L. Jackson | R. Chen | Robert Chen | W. Williams | V. Sneller | T. Lezhava | P. Benson | L. Lewis | P. Holder | R. Chen | Robert S. Thompson
[1] M. Leinonen,et al. Associations of prevaccination antibody levels with adverse reactions to pneumococcal and influenza vaccines administered simultaneously in the elderly. , 1997, Vaccine.
[2] John W. Glasser,et al. Vaccine Safety Datalink project: a new tool for improving vaccine safety monitoring in the United States. The Vaccine Safety Datalink Team. , 1997, Pediatrics.
[3] K. Nichol,et al. Side effects associated with pneumococcal vaccination. , 1997, American journal of infection control.
[4] R. Breiman,et al. Prevention of pneumococcal disease : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 1997 .
[5] J. P. Davis,et al. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[6] R. Snow,et al. Is there any connection between a second pneumonia shot and hospitalization among Medicare beneficiaries? , 1995, Public health reports.
[7] H. Konradsen,et al. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] S. Quataert,et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S , 1995, Clinical and diagnostic laboratory immunology.
[9] A. Detsky,et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. , 1994, Archives of internal medicine.
[10] A. Lanier,et al. Immunogenicity of pneumococcal revaccination in patients with chronic disease. , 1994, Archives of internal medicine.
[11] D. Musher,et al. Antibody to capsular polysaccharides of Streptococcus pneumoniae: prevalence, persistence, and response to revaccination. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] R. Adair,et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. , 1991, The New England journal of medicine.
[13] M. Mufson,et al. Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination. , 1991, Vaccine.
[14] M. First,et al. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. , 1986, Archives of internal medicine.
[15] S. Sarnaik,et al. Revaccination with polyvalent pneumococcal vaccine in children with sickle cell anemia. , 1986, The American journal of pediatric hematology/oncology.
[16] K. Edwards,et al. Pneumococcal vaccine in normal children. Primary and secondary vaccination. , 1983, American journal of diseases of children.
[17] J. Rigau-Pérez,et al. Reactions to booster pneumococcal vaccination in patients with sickle cell disease , 1983, Pediatric infectious disease.
[18] M. Hilleman,et al. Vaccination and Revaccination with Polyvalent Pneumococcal Polysaccharide Vaccines in Adults and Infants , 1978, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.